FMH James M Stockman Cancer Institute — Frederick, Maryland

FMH James M Stockman Cancer Institute is a clinical research site located in Frederick, Maryland, United States 21702.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

FMH James M Stockman Cancer Institute has participated in 17 clinical trials with 15 currently active.

Therapeutic areas: Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma.

Sponsors: National Cancer Institute (NCI), Incyte Corporation, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for FMH James M Stockman Cancer Institute?

FMH James M Stockman Cancer Institute has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has FMH James M Stockman Cancer Institute conducted?

FMH James M Stockman Cancer Institute has 17 clinical trials on record, with 15 currently active. Their work covers Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma.

Is FMH James M Stockman Cancer Institute accredited by Crixeo Health?

Yes — FMH James M Stockman Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about FMH James M Stockman Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.